The Role of BiP and the IRE1α–XBP1 Axis in Rhabdomyosarcoma Pathology

• Published in: Cancers 2021-09, Vol.13 (19), p.4927
• Main Authors: Aghaei, Mahmoud, Nasimian, Ahmad, Rahmati, Marveh, Kawalec, Philip, Machaj, Filip, Rosik, Jakub, Bhushan, Bhavya, Bathaie, S. Zahra, Azarpira, Negar, Los, Marek J., Samali, Afshin, Perrin, David, Gordon, Joseph W., Ghavami, Saeid
• Format: Article
• Language: English
• Subjects: Alveoli; Antibodies; Children; Immunohistochemistry; Investigations; Kinases; Lymph nodes; Lymphatic system; Medical prognosis; Metastases; Metastasis; Musculoskeletal system; Protein folding; Proteins; Rhabdomyosarcoma; Skeletal muscle; Transcription factors; Tumor markers; Tumors
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers13194927

Background: Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma in children, and is associated with a poor prognosis in patients presenting with recurrent or metastatic disease. The unfolded protein response (UPR) plays pivotal roles in tumor development and resistance to therapy, including RMS. Methods: In this study, we used immunohistochemistry and a tissue microarray (TMA) on human RMS and normal skeletal muscle to evaluate the expression of key UPR proteins (GRP78/BiP, IRE1α and cytosolic/nuclear XBP1 (spliced XBP1-sXBP1)) in the four main RMS subtypes: alveolar (ARMS), embryonal (ERMS), pleomorphic (PRMS) and sclerosing/spindle cell (SRMS) RMS. We also investigated the correlation of these proteins with the risk of RMS and several clinicopathological indices, such as lymph node involvement, distant metastasis, tumor stage and tumor scores. Results: Our results revealed that the expression of BiP, sXBP1, and IRE1α, but not cytosolic XBP1, are significantly associated with RMS (BiP and sXBP1 p-value = 0.0001, IRE1 p-value = 0.001) in all of the studied types of RMS tumors (n = 192) compared to normal skeletal muscle tissues (n = 16). In addition, significant correlations of BiP with the lymph node score (p = 0.05), and of IRE1α (p value = 0.004), cytosolic XBP1 (p = 0.001) and sXBP1 (p value = 0.001) with the stage score were observed. At the subtype level, BiP and sXBP1 expression were significantly associated with all subtypes of RMS, whereas IRE1α was associated with ARMS, PRMS and ERMS, and cytosolic XBP1 expression was associated with ARMS and SRMS. Importantly, the expression levels of IRE1α and sXBP1 were more pronounced in ARMS than in any of the other subtypes. The results also showed correlations of BiP with the lymph node score in ARMS (p value = 0.05), and of sXBP1 with the tumor score in PRMS (p value = 0.002). Conclusions: In summary, this study demonstrates that the overall UPR is upregulated and, more specifically, that the IRE1/sXBP1 axis is active in RMS. The subtype and stage-specific dependency on the UPR machinery in RMS may open new avenues for the development of novel targeted therapeutic strategies and the identification of specific tumor markers in this rare but deadly childhood and young-adult disease.